NANOSPAIN

Related News

Nano-sized vesicles with ACE2 receptor could prevent, treat infection from current and future strains of SARS-CoV-2 [20-01-2022]
Scientists at The University of Texas MD Anderson Cancer Center and Northwestern Medicine have identified natural extracellular vesicles containing the ACE2 protein (evACE2) in the blood of COVID-19 patients that can block infection from broad strains of SARS-CoV-2 virus in preclinical studies. The study was published today in Nature Communications.

Josep Samitier joins Fraunhofer Spain Research as Director [19-01-2026]
Nanobiotechnology, Nanomedicine, Scientific Policy

Barcelona refuerza la apuesta por la biomedicina con un centro de diagnósticos y terapias avanzadas [12-01-2026]
Nanobiotechnology, Nanomedicine

Nanoparticle therapy reprograms tumor immune cells to attack cancer from within [02-01-2026]
Nanobiotechnology, Nanomedicine

Nanozigzags, a new biomaterial, can enhance cancer immunotherapy efficacy by nearly 70% [30-12-2025]
Nanobiotechnology, Nanomedicine

Josep Samitier concludes thirteen years at the helm of IBEC [17-12-2025]
Nanobiotechnology, Scientific Policy